Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Feb. 01, 2014	Feb. 02, 2013
Cash flows from operating activities:
Net income	$ 152,586	$ 131,222
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	27,335	27,755
Amortization of intangibles	55	55
Stock-based compensation expense	11,407	13,061
Excess tax benefit-stock options	(7,604)	(5,975)
Deferred income taxes	(2,993)	(9,635)
Other non-cash activity	1,417	(1,362)
Changes in operating assets and liabilities	(24,730)	2,848
Total adjustments	4,887	26,747
Net cash provided by operating activities	157,473	157,969
Cash flows from investing activities:
Purchases of short-term available-for-sale investments	(2,234,996)	(1,653,593)
Maturities of short-term available-for-sale investments	2,029,319	1,551,147
Sales of short-term available-for-sale investments	212,819	283,164
Additions to property, plant and equipment	(48,123)	(18,269)
(Increase) decrease in other assets	(3,342)	(2,048)
Net cash (used for) provided by investing activities	(44,323)	160,401
Cash flows from financing activities:
Term Loan Repayments	0	(60,108)
Dividend payments to shareholders	(106,024)	(90,679)
Repurchase of common stock	(88,963)	(17,001)
Proceeds from employee stock plans	79,600	113,770
Contingent consideration payment	(1,773)	(3,752)
(Decrease) increase in other financing activities	22,248	(1,027)
Excess tax benefit-stock options	7,604	5,975
Net cash used for financing activities	(87,308)	(52,822)
Effect of exchange rate changes on cash	(704)	1,416
Net (decrease) increase in cash and cash equivalents	25,138	266,964
Cash and cash equivalents at beginning of period	392,089	528,833
Cash and cash equivalents at end of period	$ 417,227	$ 795,797